Buy Stocks Easy | About Us
January 18, 2022
Buy Stocks Easy | Online Stocks

AMRN


Buy Amarin Corporation plc Stock (symbol: AMRN) Easy Online

Company Name: Amarin Corporation plc

Symbol: AMRN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2000

AMRN Current Share Price

Today's AMRN ( Amarin Corporation plc ) opening price: $21.2600

Yesterday's AMRN ( Amarin Corporation plc ) closing price: $21.2300

Amarin Corporation plc Stock ( symbol: AMRN ) Price Chart since IPO (2000):

12 Months Amarin Corporation plc Stock ( symbol: AMRN ) Price Chart

Popular Questions about Amarin Corporation plc Public Stock ( AMRN )

A: Amarin Corporation plc stock symbol (also called stock or share ticker) is AMRN

A: Amarin Corporation plc IPO (Initial Public Offering) took place on 2000

A: Amarin Corporation plc's stock (AMRN symbol) price at ther IPO (initial Public Offering) was $21.2600

Q: Is AMRN stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Amarin Corporation plc stock (symbol: AMRN) at the beginning of 2019, at the opening share price of $17.5000, with a minimum of $200, by now your shares would be worth $2484 and your profit would be $2284 - SHOW ONLY IF PROFIT.

Buy Amarin Corporation plc Stock Easy Online

Amarin Corporation plc Stock Ticker Price Chart since IPO:





Amarin Corporation plc Stock Price Yesterday



 


Amarin Corporation plc Stock Price – Last Week




 


Amarin Corporation plc Stock Price – Last Month




 


Amarin Corporation plc Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            https://www.fool.com/investing/2019/12/16/why-amarin-stock-is-jumping-today.aspx
                            

                                
Why Amarin Stock Is Jumping Today

                                
                                
Vascepa is now in position to become a blockbuster medication.


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/673102/amarin-gains-on-fda-approval-of-vascepa-label-expansion
                            

                                
Amarin Gains on FDA Approval of Vascepa Label Expansion

                                
                                
Amarin (AMRN) gains as FDA approves a label expansion of Vascepa to...


                            

                        
                    

                


                            

                    


                        
                            https://www.investors.com/news/technology/amarin-stock-fda-approves-vascepa-cardiovascular-risk/
                            

                                
This Biotech Stock Just Got A Highly Anticipated FDA Approval

                                
                                
Amarin stock remained halted late Friday after U.S. regulators appr...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/amarin-gets-fda-approval-for-new-vascepa-use-us-shares-remain-halted-2019-12-13
                            

                                
Amarin gets FDA approval for new Vascepa use, U.S. shares remain halted

                                
                                
Amarin Corp. AMRN, +4.92% received U.S. approval to market its drug...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/13/1960603/0/en/Amarin-Receives-FDA-Approval-of-VASCEPA-icosapent-ethyl-to-Reduce-Cardiovascular-Risk.html
                            

                                
Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk

                                
                                
VASCEPA becomes the first and only FDA-approved medication for redu...


                            

                        
                    

                


                            

                    


                        
                            https://www.youtube.com/watch?v=0-wb6STWqQM
                            

                                
Stocks Hit Highs; Tesla, Autodesk Enter Buy Zones; Amarin Reverses

                                
                                
Tesla, Autodesk enter buy zones; Amarin reverses lower.


                            

                        
                    

                


                            

                    


                        
                            https://investorplace.com/2019/12/amarin-future-choppiness/
                            

                                
Amarin Has the Kind of Future Worth the Near-Term Choppiness

                                
                                
A disappointing label verdict from the Food and Drug Administration...


                            

                        
                    

                


                            

                    


                        
                            https://www.fool.com/investing/2019/12/16/why-amarin-stock-is-jumping-today.aspx
                            

                                
Why Amarin Stock Is Jumping Today

                                
                                
Vascepa is now in position to become a blockbuster medication.


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/673102/amarin-gains-on-fda-approval-of-vascepa-label-expansion
                            

                                
Amarin Gains on FDA Approval of Vascepa Label Expansion

                                
                                
Amarin (AMRN) gains as FDA approves a label expansion of Vascepa to...


                            

                        
                    

                


                            

                    


                        
                            https://www.investors.com/news/technology/amarin-stock-fda-approves-vascepa-cardiovascular-risk/
                            

                                
This Biotech Stock Just Got A Highly Anticipated FDA Approval

                                
                                
Amarin stock remained halted late Friday after U.S. regulators appr...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/amarin-gets-fda-approval-for-new-vascepa-use-us-shares-remain-halted-2019-12-13
                            

                                
Amarin gets FDA approval for new Vascepa use, U.S. shares remain halted

                                
                                
Amarin Corp. AMRN, +4.92% received U.S. approval to market its drug...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.